Expert Ratings
Easily search Stocks, Mutual Funds, eBooks, Articles and Videos
Track the companies of Group.
| Sales Growth | Profit Growth | Expense Growth | Stock Price CAGR |
|---|---|---|---|
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company’s shares trade on the Bombay Stock Exchange and the National Stock Exchange in India and on the New York Stock Exchange in the United States.
Business area of the company
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Products
Generics
In 1984 a company whose motto is Good Health Can't-Wait started its journey by laying its first stone in Hyderabad Telangana. Dr Reddy is an Indian multinational pharmaceutical company founded by Anji Reddy. They started their journey as a drug supplier in the Indian subcontinent. Still, They later expanded their horizons to unregulated markets, which helped them gain profits, fame, and approval from the FDA to enter the bigger regulated ones like the USA and UK. Within a year, Reddy's became the first Indian company to export the active ingredients for pharmaceuticals to Europe. Crossing the three-year mark, Dr. Reddy entered into the manufacturing of pharma drugs. As of the year 2007, Dr. Reddy had seven plants producing active pharma ingredients, out of which five were in India, and two of them were in the UK. With over 190 medications, 60 active ingredients, Dr. Reddy's net income stands strong at 270 million USD. Major markets they operate in are the USA, India, Russia & CIS countries, and Europe.
They are into three different businesses across the globe.
Pharmaceutical Services and Active Ingredients
Global Generics
Proprietary Products
Apart from APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations Dr. Reddy,s major med areas include
GastrointestinalInvest Yadnya is a company that educates and simplifies the concepts of personal finance for each individual. We have amalgamated technology with financial planning expertise to help an individual meet their financial objectives. We invest time, money, and knowledge to build financial literacy in India.
We offer various products and services including, Personalized Financial Planning, Stock Market Analysis with eBook Subscriptions, Simplest Income Tax Information Bank, Comprehensive Mutual Fund Reviews, and Do-It-Yourself Financial Planning.
Invest Yadnya should be a choice because it offers unbiased and transparent stock analysis reports. Our work is knowledge-based and has specific proprietary methodologies and a stock research framework. We continuously keep updating our data and have the latest information available.
We help our clients do extensive research on 950+ companies, including Dr. Reddy stock analysis. You can find the latest Dr. Reddy stock price on Invest Yadnya. We also provide our clients with the Dr Reddy balance sheet. It helps the clients understand the financial position of the company before making any investment decisions. The Dr. Reddy analysis helps the investors identify the intrinsic worth of the security. Dr. Reddy results provide a summary of how the business incurs revenues and expenses. We also offer our clients with Dr. Reddy share price graphs.
Detailed Stock Articles on Dr Reddy's Laboratories vs Cipla Stock Comparison: Part 1 & Part 2 are provided on our website, which offers an in-depth Dr Reddy stock review. It gives an investor a sense of whether the company is growing, stable or deteriorating. This helps investors make a viable investment decision with a thorough discussion on Dr. Reddy annual report.
Invest Yadnya offers numerous resources for Dr. Reddy share analysis. With the available Dr Reddy's Laboratories financial statements, price chart, ratios, etc., get a detailed analysis of the company. With Invest Yadnya’s available resources, get an overview of the company, both from the qualitative and financial perspective. The investors shall make a viable investment decision depending on your risk profile & other economic factors.
Dr Reddy's Laboratories analysis gives the clients a better understanding of the company’s EPS, Debt-Equity Ratio etc. It helps clients take the first step in choosing which companies to invest in.
Dr Reddy's Laboratories’ economic analysis helps allocate the equity in the Portfolio of an investor to add to its favourable returns.
To find the Dr Reddy Performance analysis & Dr Reddy stock chart, subscribe to our Equity Research and Stock Fundamental Analysis Tool, Stock-O-Meter.
Our website has information about 113 other Pharmaceuticals & Drugs companies that give insight into its financials. Companies include Divis Laboratories, Cipla, Sun Pharmaceutical Industries, Biocon, Aurobindo Pharma, Lupin, Torrent Pharmaceuticals, Cadila Healthcare, Abbott India, Glaxosmithkline Pharmaceuticals & many more.
Comment